Zevra Therapeutics

ZVRANasdaq United States Health Care Biotechnology: Pharmaceutical Preparations

Market cap

$686.477 M

$11.56 -2.69%

Close of 7 Aug 2026

Revenue

—

Not reported

Earnings

$83.2M

#1379 by earnings

Shares outstanding

59,383,781

Latest filing cover page

P/E ratio

8.2

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations — ranked by market cap

All 501 →

#188Ironwood PharmaceuticalsIRWD$711.1M
#189Phathom PharmaceuticalsPHAT$691.7M
#190Zevra TherapeuticsZVRA$686.5M
#191NeurogeneNGNE$682.2M
#192Immix BiopharmaIMMX$678.4M

Where these numbers come from

Share counts and financials for Zevra Therapeutics are taken from its own SEC filings via EDGAR — public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 9 Aug 2026. Read the methodology.